[Dialytic therapy in severely burnt patients with acute renal failure].
BACKGROUND
Appearance of acute renal failure (ARF) in severely burnt patients (GU) is a serious complication. It has a negative prognostic value and almost always develops in the context of multiple organ dysfunction syndrome (MODS) induced by sepsis. Over the last 20 years, according to data available, the mortality rate has been reported to reach about 75%. We have analyzed the initial results obtained in GU patients who were admitted to the Intensive Care Unit of the Burns Center in Turin.


METHODS
Out of 105 GU patients admitted between July 1999 and September 2000 (burned surface area (BSA) 23.8%, range 2-95%, mortality rate 13.7%), 7 patients (6.4%) had complications of ARF requiring extracorporeal dialytic therapy (38 HF sessions lasting 4-6 hours, 2 HF + 12 HDF + 1 UF sessions lasting 8-11 hours).


RESULTS
Total BSA of 7 GU patients with ARF was 62.5+/-11.3% (mean +/-SEM). Mortality rate was 71.4% which was due to septic shock and MODS. ARF onset was at 28.4+/-8.4 days from admission. Dialytic treatment started at Crs 2.3+/-0.42 mg/dl, and patients were treated for 7.6+/-3.5 days with a weight loss of 1859+/-161 gr/die. Circuit anticoagulation was obtained by minimal amount of heparin (132.2+/-26.5 U/hour) and no hemorrhagic complications were observed.


CONCLUSIONS
In GU patients with ARF the dialytic treatment with daily long-lasting convective- diffusive techniques permitted us to achieve a survival and dialytic adequacy similar to those reported with continuous renal replacement therapies; however, mortality rate is high and related to septic shock and MODS.
Dipartimento di Area Medica, U. O. Autonoma di Nefrologia e Dialisi, Torino, Italy.
G
G
Triolo
F
F
Mariano
M
M
Stella
M
M
Salomone
G
G
Magliacani
D058186:Acute Kidney Injury / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D002053:Burn Units / Q000706:statistics & numerical data; D002056:Burns / Q000150:complications* / Q000401:mortality / Q000601:surgery / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D005440:Fluid Therapy; D006440:Hemofiltration / Q000706:statistics & numerical data; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000209:etiology / Q000401:mortality; D006435:Renal Dialysis / Q000379:methods / Q000706:statistics & numerical data; D012189:Retrospective Studies; D012772:Shock, Septic / Q000209:etiology / Q000401:mortality; D013262:Stevens-Johnson Syndrome / Q000150:complications; D013566:Sympathomimetics / Q000627:therapeutic use; D016896:Treatment Outcome
D000925:Anticoagulants; D013566:Sympathomimetics